Literature DB >> 33657385

Treatment regimens may compromise gut-microbiome-derived signatures for liver cirrhosis.

Sicheng Wu1, Puzi Jiang1, Xing-Ming Zhao2, Wei-Hua Chen3.   

Abstract

Many of the gut-microbiome-derived signatures for liver cirrhosis, especially the important ones, were likely under the influence of proton pump inhibitors (PPIs). Wu et al. suggest that drug usage is a confounding factor in metagenomics analysis that should be controlled for.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33657385     DOI: 10.1016/j.cmet.2021.02.012

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  4 in total

1.  GMrepo v2: a curated human gut microbiome database with special focus on disease markers and cross-dataset comparison.

Authors:  Die Dai; Jiaying Zhu; Chuqing Sun; Min Li; Jinxin Liu; Sicheng Wu; Kang Ning; Li-Jie He; Xing-Ming Zhao; Wei-Hua Chen
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

2.  mBodyMap: a curated database for microbes across human body and their associations with health and diseases.

Authors:  Hanbo Jin; Guoru Hu; Chuqing Sun; Yiqian Duan; Zhenmo Zhang; Zhi Liu; Xing-Ming Zhao; Wei-Hua Chen
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

3.  Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver Disease.

Authors:  Russell R Fling; Timothy R Zacharewski
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

4.  Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis.

Authors:  Hui Lu; Na L Gao; Fan Tong; Jiaojiao Wang; Huanhuan Li; Ruiguang Zhang; Hong Ma; Nong Yang; Yongchang Zhang; Ye Wang; Zhiwen Liang; Hao Zeng; Wei-Hua Chen; Xiaorong Dong
Journal:  Microbiol Spectr       Date:  2021-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.